The DOI matches its Crossref record; 252 of the 252 references it cites were found in a registry or an index.
The evolution of SARS-CoV-2
Open accessAbstract
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused millions of deaths and substantial morbidity worldwide. Intense scientific effort to understand the biology of SARS-CoV-2 has resulted in daunting numbers of genomic sequences. We witnessed evolutionary events that could mostly be inferred indirectly before, such as the emergence of variants with distinct phenotypes, for example transmissibility, severity and immune evasion. This Review explores the mechanisms that generate genetic variation in SARS-CoV-2, underlying the within-host and population-level processes that underpin these events. We examine the selective forces that likely drove the evolution of higher transmissibility and, in some cases, higher severity during the first year of the pandemic and the role of antigenic evolution during the second and third years, together with the implications of immune escape and reinfections, and the increasing evidence for and potential relevance of recombination. In order to understand how major lineages, such as variants of concern (VOCs), are generated, we contrast the evidence for the chronic infection model underlying the emergence of VOCs with the possibility of an animal reservoir playing a role in SARS-CoV-2 evolution, and conclude that the former is more likely. We evaluate uncertainties and outline scenarios for the possible future evolutionary trajectories of SARS-CoV-2.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The higher end of the ranges, with evolutionary rates up to 8 × 10 -3 substitutions per site per year, emphasises the potential for SARS-CoV-1 and similar coronaviruses to evolve rapidly, possibly even quicker than SARS-CoV-2.126”
From Severe acute respiratory syndrome (SARS) mathematical models and disease parameters: a systematic review (2025) · cites this paper as [126]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hoffmann, M., Kleine-Weber, H., Schroeder, S., Krüger, N., Herrler, T., Erichsen, S., Schiergens, T. S., Herrler, G., Wu, N.-H., Nitsche, A., et al. (2020) · Cell · doi:10.1016/j.cell.2020.02.052 · Cited by 20,286
EVOLUTION IN MENDELIAN POPULATIONS
Wright, S. (1931) · Genetics · doi:10.1093/genetics/16.2.97 · Cited by 9,237
Virological assessment of hospitalized patients with COVID-2019
Wölfel, R., Corman, V. M., Guggemos, W., Seilmaier, M., Zange, S., Müller, M. A., Niemeyer, D., Jones, T. C., Vollmar, P., Rothe, C., et al. (2020) · Nature · doi:10.1038/s41586-020-2196-x · Cited by 6,661
Origin and evolution of pathogenic coronaviruses
Cui, J., Li, F., & Shi, Z. (2018) · Nature Reviews Microbiology · doi:10.1038/s41579-018-0118-9 · Cited by 5,729
Korber, B., Fischer, W. M., Gnanakaran, S., Yoon, H., Theiler, J., Abfalterer, W., Hengartner, N., Giorgi, E. E., Bhattacharya, T., Foley, B., et al. (2020) · Cell · doi:10.1016/j.cell.2020.06.043 · Cited by 4,281
Coronaviruses: An Overview of Their Replication and Pathogenesis
Fehr, A. R., & Perlman, S. M. (2015) · Methods in molecular biology · doi:10.1007/978-1-4939-2438-7_1 · Cited by 3,910
Structural basis of receptor recognition by SARS-CoV-2
Shang, J., Ye, G., Shi, K., Wan, Y., Luo, C., Aihara, H., Geng, Q., Auerbach, A., & Li, F. (2020) · Nature · doi:10.1038/s41586-020-2179-y · Cited by 3,661
SARS-CoV-2 variants, spike mutations and immune escape
Harvey, W. T., Carabelli, A. M., Jackson, B., Gupta, R. K., Thomson, E. C., Harrison, E. M., Ludden, C., Reeve, R., Rambaut, A., COVID-19 Genomics UK (COG-UK) Consortium, et al. (2021) · Nature Reviews Microbiology · doi:10.1038/s41579-021-00573-0 · Cited by 3,528
Nextstrain: real-time tracking of pathogen evolutionPreprint
Hadfield, J., Megill, C., Bell, S. M., et al. (2017) · bioRxiv · doi:10.1101/224048 · Cited by 3,172
Nextstrain: real-time tracking of pathogen evolution
Hadfield, J., Megill, C., Bell, S. M., Huddleston, J., Potter, B., Callender, C., Sagulenko, P., Bedford, T., & Neher, R. A. (2018) · Bioinformatics · doi:10.1093/bioinformatics/bty407 · Cited by 3,154
Cited by
Sorted by citations
Items 201–300 of 998
Mah, M. G., Zeller, M. A., Zhang, R., Zhuang, Y., Maro, V. P., Crump, J. A., Rubach, M. P., Ooi, E. E., Low, J. G. H., Wang, D. Y., et al. (2024) · npj Viruses · doi:10.1038/s44298-024-00058-w · Cited by 10
Unveiling the ghost: machine learning’s impact on the landscape of virology
Bowyer, S., Allen, D. J., & Furnham, N. (2025) · Journal of General Virology · doi:10.1099/jgv.0.002067 · Cited by 13
Sumsuzzman, D. M., Ye, Y., Wang, Z., Pandey, A., Langley, J. M., Galvani, A. P., & Moghadas, S. M. (2025) · BMC Infectious Diseases · doi:10.1186/s12879-025-10610-5 · Cited by 12
A randomized phase I trial of intranasal SARS-CoV-2 vaccine dNS1-RBD in children aged 3–17 years
Chu, K., Quan, J., Liu, X., Chen, Q., Zang, X., Jiang, H.-M., Liu, D., Chu, X., Zhuang, C., Han, J., et al. (2025) · npj Vaccines · doi:10.1038/s41541-025-01096-y · Cited by 9
Pregnancy reduces COVID-19 vaccine immunity against novel variants
Parish, M. A., Sachithanandham, J., Gutierrez, L., Park, H.-S., Yin, A., Roznik, K., Creisher, P. S., Lee, J. S., Clair, L. A. S., Werner, A., et al. (2025) · npj Vaccines · doi:10.1038/s41541-025-01236-4 · Cited by 9
Joseph, R., Marais, G. J. K., Iranzadeh, A., Alisoltani, A., Hardie, D. R., Davies, M., Heekes, A., Chetty, N., Timmerman, V., Hsiao, M., et al. (2025) · Journal of Virology · doi:10.1128/jvi.00780-25 · Cited by 8
Common cold embecovirus imprinting primes broadly neutralizing antibody responses to SARS-CoV-2 S2
Changrob, S., Yasuhara, A., Park, S., Bangaru, S., Li, L., Troxell, C. A., Halfmann, P., Erickson, S. A., Catanzaro, N., Yuan, M., et al. (2025) · The Journal of Experimental Medicine · doi:10.1084/jem.20251146 · Cited by 9
SARS-CoV-2 wastewater genomic surveillance: approaches, challenges, and opportunities
Munteanu, V., Saldana, M. A., Dreifuss, D., Ouyang, W. O., Ferdous, J., Mohebbi, F., Roseberry, J. S., Ciorbă, D., Bostan, V., Gordeev, V., et al. (2026) · Genome biology · doi:10.1186/s13059-025-03927-6 · Cited by 9
Asthana, A., Corona, A., Shin, W.-J., Kwak, M.-J., Gaughan, C., Tramontano, E., Jung, J. U., Schobert, R., Jha, B. K., Silverman, R. H., et al. (2023) · Viruses · doi:10.3390/v15071539 · Cited by 9
Stokanic, M. M., Simović, A., Jovanović, V. B., Radomirović, M., Udovički, B., Ristivojević, M. K., Djukic, T., Vasović, T. D., Aćimović, J. M., Sabljić, L., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms25010333 · Cited by 9
Zhou, Z., Zheng, H., Xiao, G., Xie, X., Rang, J., & Peng, D. (2024) · BMC Infectious Diseases · doi:10.1186/s12879-023-08944-z · Cited by 9
Popovic, M. E., Šekularac, G. M., & Popović, M. (2024) · Microbial Risk Analysis · doi:10.1016/j.mran.2024.100290 · Cited by 9
Malar, D. S., Verma, K., Prasanth, M. I., Tencomnao, T., & Brimson, J. M. (2024) · Scientific Reports · doi:10.1038/s41598-024-55013-9 · Cited by 9
Popovic, M. E., Stevanović, M., & Mihailović, M. (2024) · Journal of the Serbian Chemical Society · doi:10.2298/jsc240119019p · Cited by 9
Donker, T., Papathanassopoulos, A., Ghosh, H., Kociurzynski, R., Felder, M., Grundmann, H., & Reuter, S. (2024) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2314262121 · Cited by 9
Acute Actions of Natriuretic Peptides in Coronary Vasculature and Ischaemic Myocardium
Rautureau, Y., & Baxter, G. F. (2004) · Current Pharmaceutical Design · doi:10.2174/1381612043383854 · Cited by 9
Ragoobir, J., Abayasekara, D. R. E., Bruckdorfer, K. R., & Michael, A. E. (2002) · Journal of Endocrinology · doi:10.1677/joe.0.1730103 · Cited by 9
Lythgoe, K., Golubchik, T., Hall, M. D., House, T., Cahuantzi, R., MacIntyre-Cockett, G., Fryer, H. R., Thomson, L., Nurtay, A., Ghafani, M., et al. (2022) · medRxiv · doi:10.1101/2022.01.05.21268323 · Cited by 9
Self-citationCoombes, N. S., Bewley, K. R., Duff, Y. L., Alami-Rahmouni, N., Ryan, K. A., Kempster, S. L., Ferguson, D., Davies, E. R., Weldon, T. M., Cross, E. S., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.10.21.563398 · Cited by 9
Long-read reconstruction of many diverse haplotypes with deviderPreprint
Shaw, J., Boucher, C. A., Yu, Y. W., Noyes, N. R., & Li, H. (2025) · Genome Research · doi:10.1101/gr.280510.125 · Cited by 10
Modeling viral evolution: A novel SIRSVIDE framework with application to SARS-CoV-2 dynamics
Jin, K., Tang, X., Qian, Z., Wú, Z., Yang, Z., Qian, T., Hon, C., & Lü, J. (2024) · hLife · doi:10.1016/j.hlife.2024.03.006 · Cited by 9
Vitamin D Supplementation in Neonatal and Infant MIS-C Following COVID-19 Infection
Rizzi, M., Avellis, V., Messina, A., Germano, C., Tavella, E., Dodaro, V., Vitale, R., Revelli, A., Zola, P., Picone, S., et al. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25073712 · Cited by 8
Gong, X., Peng, L., Wang, F., Liu, J., Tang, Y., Peng, Y., Niu, S., Yin, J., Guo, L., Lu, H., et al. (2024) · Journal of Infection · doi:10.1016/j.jinf.2024.106208 · Cited by 8
Euzen, V., Xhaard, A., Berreira-Ibraim, S., Deville, L., Quentin, A., Prata, P. H., Gournay, V., Prot, M., Rahou, Y., Barbet, M., et al. (2024) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2024.107281 · Cited by 8
Breaking the Chain: Protease Inhibitors as Game Changers in Respiratory Viruses Management
Papaneophytou, C. P. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25158105 · Cited by 8
Su, H.-C., Chang, Y.-C., Chen, C.-H., Cheng, M.-Y., Hsih, W.-H., Chen, Y.-J., Chou, C.-H., Lin, Y., Hsiao, C.-T., Shih, H.-M., et al. (2024) · Journal of Microbiology Immunology and Infection · doi:10.1016/j.jmii.2024.08.003 · Cited by 8
Essink, B. J., Shapiro, C., Isidro, M. G. D., Bradley, P., Pragalos, A., Bloch, M., Santiaguel, J., Frias, M. V., Miyakis, S., Alves de Mesquita, M., et al. (2024) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2024.2408863 · Cited by 8
Stepanova, E., Matyushenko, V., Mezhenskaya, D. А., Bazhenova, E. A., Kotomina, T. S., Rak, A. Y., Donina, S., Chistyakova, A. K., Kostromitina, A. D., Novitskaya, V., et al. (2024) · Vaccines · doi:10.3390/vaccines12121300 · Cited by 7
Fragoso-Saavedra, M., & Liu, Q. (2025) · Virology · doi:10.1016/j.virol.2025.110412 · Cited by 10
Nakamura, S., Tanimura, Y., Nomura, R., Suzuki, H., Nishikawa, K., Kamegawa, A., Numoto, N., Tanaka, A., Kawabata, S., Sakaguchi, S., et al. (2025) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2413465122 · Cited by 8
Shrestha, K. P., Kim, S., Han, J., Zhang, M., Parajuli, S., & Cho, G. (2025) · Microsystems & Nanoengineering · doi:10.1038/s41378-025-00972-w · Cited by 8
Scenario Projections of COVID-19 Burden in the US, 2024-2025
Loo, S. L., Jung, S.-M., Contamin, L., Howerton, E., Bents, S. J., Hochheiser, H., Runge, M. C., Smith, C. P., Carcelén, E. C., Yan, K., et al. (2025) · JAMA Network Open · doi:10.1001/jamanetworkopen.2025.32469 · Cited by 8
Cao, G., Xu, C., Wang, L., Chai, K., & Wu, B. (2025) · Viruses · doi:10.3390/v17111457 · Cited by 8
SARS-CoV-2 variant biology and immune evasion
Zaidi, A. K., & Singh, R. B. (2024) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2023.11.007 · Cited by 8
Arming up against Omicron subvariants
Altmann, D. M., & Boyton, R. J. (2024) · Cell Host & Microbe · doi:10.1016/j.chom.2024.01.010 · Cited by 8
Can inflammatory plasma proteins predict Long COVID or Fatigue severity after SARS-CoV-2 infection?
Schmitz, T., Freuer, D., Goßlau, Y., Warm, T. D., Hyhlik-Dürr, A., Linseisen, J., Meisinger, C., & Kirchberger, I. (2024) · Virus Research · doi:10.1016/j.virusres.2024.199363 · Cited by 8
Crykey: Rapid identification of SARS-CoV-2 cryptic mutations in wastewater
Liu, Y., Sapoval, N., Gallego‐García, P., Tomás, L., Posada, D., Treangen, T. J., & Stadler, L. B. (2024) · Nature Communications · doi:10.1038/s41467-024-48334-w · Cited by 8
Long-term serial passaging of SARS-CoV-2 reveals signatures of convergent evolution
Foster, C. S. P., Walker, G. J., Jean, T., Wong, M., Brassil, L., Isaacs, S. R., Lyu, Y., Turville, S. G., Kelleher, A. D., & Rawlinson, W. D. (2025) · Journal of Virology · doi:10.1128/jvi.00363-25 · Cited by 11
The emergence of metabolisms through Earth history and implications for biospheric evolution
Moody, E. R. R., Williams, T. A., Álvarez-Carretero, S., Szöllősi, G. J., Pisani, D., Lenton, T. M., & Donoghue, P. C. J. (2025) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2024.0097 · Cited by 12
Ali, M. A., & Caetano‐Anollés, G. (2024) · Biology · doi:10.3390/biology13030134 · Cited by 11
Editorial: Predicting virus evolution: from genome evolution to epidemiological trends
Zwart, M. P., Kupczok, A., & Iranzo, J. (2023) · Frontiers in Virology · doi:10.3389/fviro.2023.1215709 · Cited by 8
Newer emerging SARS-COV2 variant: Omicron EG.5
Yadav, S., Zaman, K., Bashyal, P., Bhatta, R., Bhandari, S., Mohanty, A., & Sah, R. (2023) · Annals of Medicine and Surgery · doi:10.1097/ms9.0000000000001386 · Cited by 8
Xiong, D., Zhang, X., Xu, B., Shi, M., Chen, M., Dong, Z., Zhong, J., Gong, R., Wu, C., Li, J., et al. (2024) · Gene · doi:10.1016/j.gene.2024.148306 · Cited by 7
Lessons learnt on infectious bronchitis virus lineage GI-23
Finger, A., Ashash, U., Goldenberg, D., & Raviv, Z. (2024) · Avian Pathology · doi:10.1080/03079457.2024.2398030 · Cited by 9
Vishwanath, S., Carnell, G., Billmeier, M., Ohlendorf, L., Neckermann, P., Asbach, B., George, C. L., Sans, M. S., Chan, A., Olivier, J., et al. (2024) · npj Vaccines · doi:10.1038/s41541-024-00950-9 · Cited by 7
Mao, T., Nan, L., & Shum, H. C. (2024) · Analytical Chemistry · doi:10.1021/acs.analchem.4c02429 · Cited by 7
A Global Collaborative Comparison of SARS-CoV-2 Antigenicity Across 15 Laboratories
Brangel, P., Türeli, S., Mühlemann, B., Liechti, N., Zysset, D., Engler, O. B., Hunger‐Glaser, I., Ghiga, I., Mattiuzzo, G., Eckerle, I., et al. (2024) · Viruses · doi:10.3390/v16121936 · Cited by 8
D614G reshapes allosteric networks and opening mechanisms of SARS-CoV-2 spikes
Kearns, F. L., Bogetti, A. T., Calvó‐Tusell, C., Braza, M. K. E., Casalino, L., Gramm, A. J., Braet, S. M., Rosenfeld, M. A., Rajapaksha, H., Barker, B., et al. (2026) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2504793123 · Cited by 7
Akingbola, A., Adewole, O., Adegbesan, A., Peters, F., Odukoya, T., Aremu, O., Adeleke, O., Idris, A., Owolabi, A., & Aiyenuro, A. (2025) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2025.2485840 · Cited by 7
Modeling SARS-CoV-2 Infection Dynamics: Insights into Viral Clearance and Immune Synergy
Fan, L., Qiu, Z., Deng, Q., Guo, T., & Rong, L. (2025) · Bulletin of Mathematical Biology · doi:10.1007/s11538-025-01442-0 · Cited by 6
The Role of TDP-43 in SARS-CoV-2-Related Neurodegenerative Changes
Kim, D., Kim, J., Jeon, M., Kim, K., Kim, D.-G., & Choi, I.-S. (2025) · Viruses · doi:10.3390/v17050724 · Cited by 8
SARS-CoV-2 Replication Revisited: Molecular Insights and Current and Emerging Antiviral Strategies
Subong, B. J. J., & Forteza, I. L. (2025) · COVID · doi:10.3390/covid5060085 · Cited by 7
Mutation T9I in Envelope confers autophagy resistance to SARS-CoV-2 Omicron
Klute, S., Nchioua, R., Cordsmeier, A., Vishwakarma, J., Koepke, L., Alshammary, H., Jung, C., Hirschenberger, M., Hoenigsperger, H., Fischer, J.-R., et al. (2025) · iScience · doi:10.1016/j.isci.2025.112974 · Cited by 9
JNK kinase regulates phosphorylation of HCoV-229E nucleocapsid protein
Brüggemann, Y., Meister, T. L., Heinen, N., Richter, E., Westhoven, S., Poppe, M., Shaban, M. S., Sirkinti, L., Nocke, M. K., Tödt, D., et al. (2025) · npj Viruses · doi:10.1038/s44298-025-00152-7 · Cited by 7
Rationalizing recommendations for influenza and COVID-19 vaccines
Breznik, J. A., Miller, M. S., & Bowdish, D. M. E. (2025) · Vaccine · doi:10.1016/j.vaccine.2025.127775 · Cited by 9
Muthuraman, K., Jackman, M. J., Liang, Y., Garrett, M. E., Cui, H., Nguyen, L. V. H., Ivanochko, D., Ye, C., Pino, P. A., Hicks, A., et al. (2025) · Journal of Virology · doi:10.1128/jvi.01523-25 · Cited by 7
Whitcomb, L. A., Berry, K., LaVergne, S. M., Natter, N., Baxter, B. A., Rao, S., Tipton, M., Gritsenko, M. A., Weitz, K., Gerbasi, V. R., et al. (2025) · BMC Infectious Diseases · doi:10.1186/s12879-025-11824-3 · Cited by 7
Um, H., Kim, S., Hwang, J., Lee, Y., Wang, S. X., & Lee, J. (2025) · BioChip Journal · doi:10.1007/s13206-025-00244-9 · Cited by 7
Lamb, K. D., Hughes, J., Lytras, S., Young, F., Koci, O., Herzig, J. C., Lovell, S. C., Grove, J., Yuan, K., & Robertson, D. L. (2026) · Nature Communications · doi:10.1038/s41467-026-69569-9 · Cited by 20
Nigam, D., Muthukrishnan, E., Flores-López, L. F., Nigam, M., & Wamaitha, M. J. (2023) · Plants · doi:10.3390/plants12101995 · Cited by 7
Kim, D., Kim, J.-S., Kim, M., Park, H., Maharjan, S., Baek, K., Kang, B. M., Kim, S., Park, S., Park, M., et al. (2023) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2023.1280686 · Cited by 7
Plans-Rubió, P. (2023) · Vaccines · doi:10.3390/vaccines11121836 · Cited by 7
Melenotte, C., Chavarot, N., L’Honneur, A.-S., Bodard, S., Cheminant, M., Flahault, A., Nguyen, Y., Burgard, M., Dannaoui, É., Bougnoux, M., et al. (2024) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofae012 · Cited by 9
Tang, J., Xu, Q., Zhu, C., Xuan, K., Li, T., Li, Q., Pang, X., Zha, Z., Li, J., Qiao, L., et al. (2024) · Vaccines · doi:10.3390/vaccines12020175 · Cited by 7
Genomic Surveillance and Mutation Analysis of SARS-CoV-2 Variants among Patients in Saudi Arabia
Alsuwairi, F. A., Alsaleh, A. N., Obeid, D. A., Al-Qahtani, A. A., Almaghrabi, R. S., Alahideb, B. M., AlAbdulkareem, M. A., Alsanea, M. S., Alharbi, L., Althawadi, S., et al. (2024) · Microorganisms · doi:10.3390/microorganisms12030467 · Cited by 7
White, C. L., Glover, M. A., Gandhapudi, S. K., Richards, K. A., & Sant, A. J. (2024) · Vaccines · doi:10.3390/vaccines12030281 · Cited by 5
Lenarda, A. D., Ferri, N., Lanzafame, M., Montuori, E. A., & Pacelli, L. (2024) · European Cardiology Review · doi:10.15420/ecr.2024.04 · Cited by 8
(R)evolution of Viruses: Introduction to biothermodynamics of viruses
Popovic, M. E., Tadić, V. M., & Popović, M. (2024) · Virology · doi:10.1016/j.virol.2024.110319 · Cited by 7
Vosoughi, P., Naghib, S. M., Rahmanian, M., & Mozafari, M. R. (2025) · Current Topics in Medicinal Chemistry · doi:10.2174/0115680266325847241121034100 · Cited by 7
McClure, C. P., Tsoleridis, T., Hill, J. D., Holmes, N., Chappell, J. G., Byaruhanga, T., Duncan, J. D., Tofan, M., Berry, L., Clark, G., et al. (2025) · Microbial Genomics · doi:10.1099/mgen.0.001451 · Cited by 8
LSDV-Vectored SARS-CoV-2 S and N Vaccine Protects against Severe Clinical Disease in Hamsters
de Moor, W. R. J., Williamson, A., Schäfer, G., Douglass, N., Gers, S., Sutherland, A. D., Blumenthal, M. J., Margolin, E., Shaw, M. L., Preiser, W., et al. (2023) · Viruses · doi:10.3390/v15071409 · Cited by 7
Cunningham, C. L., Frye, C. J., Makowski, J. A., Kensinger, A. H., Shine, M., Milback, E. J., Lackey, P. E., Evanseck, J. D., & Mihailescu, M. (2023) · RNA · doi:10.1261/rna.079627.123 · Cited by 7
Detecting Episodic Evolution through Bayesian Inference of Molecular Clock Models
Tay, J. H., Baele, G., & Duchêne, S. (2023) · Molecular Biology and Evolution · doi:10.1093/molbev/msad212 · Cited by 7
The Development of the SARS-CoV-2 Epidemic in Different Regions of Siberia in the 2020–2022 Period
Palyanova, N. V., Sobolev, I. A., Palyanov, A. Y., Kurskaya, O., Komissarov, A. B., Danilenko, D., Fadeev, A. V., & Shestopalov, A. M. (2023) · Viruses · doi:10.3390/v15102014 · Cited by 7
Zhakparov, D., Quirin, Y., Xiao, Y. Q., Battaglia, N., Holzer, M. S., Bühler, M., Kistler, W., Engel, D. C., Zumthor, J. P., Caduff, A., et al. (2023) · Microorganisms · doi:10.3390/microorganisms11112660 · Cited by 7
Fanelli, M., Petrone, V., Maracchioni, C., Chirico, R., Cipriani, C., Coppola, L., Malagnino, V., Teti, E., Sorace, C., Zordan, M., et al. (2023) · Current Research in Microbial Sciences · doi:10.1016/j.crmicr.2023.100215 · Cited by 7
Ravi, V., Shamim, U., Khan, M. A., Swaminathan, A., Mishra, P., Rajender, S., Bharali, P., Chauhan, N. S., & Pandey, R. (2024) · Frontiers in Medicine · doi:10.3389/fmed.2023.1294699 · Cited by 7
Wang, C. X., Kohli, R., Olaker, V. R., Terebuh, P., Xu, R., Kaelber, D. C., & Davis, P. B. (2024) · Molecular Psychiatry · doi:10.1038/s41380-024-02414-x · Cited by 7
Cianfarini, C. L., Hassler, L., Wysocki, J. A., Hassan, A., Nicolaescu, V. I., Elli, D., Gula, H., Ibrahim, A. M., Randall, G. C., Henkin, J., et al. (2024) · Cells · doi:10.3390/cells13030203 · Cited by 7
Advancements in SARS-CoV-2 detection: Navigating the molecular landscape and diagnostic technologies
Almulla, N., Soltane, R., Alasiri, A., Allayeh, A. K., Alqadi, T., Alshehri, F., Alrokban, A. H., Zaghlool, S. S., Zayan, A. Z., Abdalla, K. F., et al. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e29909 · Cited by 7
RetractedAmeratunga, R., Jordan, A., Lehnert, K., Leung, E. Y., Mears, E., Snell, R. G., Steele, R., & Woon, S. (2024) · Antiviral Research · doi:10.1016/j.antiviral.2024.105894 · Cited by 8
Colonna, G. (2024) · Livers · doi:10.3390/livers4020016 · Cited by 7
Hoeggerl, A. D., Nunhofer, V., Weidner, L., Lauth, W., Zimmermann, G., Badstuber, N., Grabmer, C., Kartal, O., Jungbauer, C., Neureiter, H., et al. (2024) · Scandinavian Journal of Infectious Diseases · doi:10.1080/23744235.2024.2367112 · Cited by 7
The Ambivalence of Post COVID-19 Vaccination Responses in Humans
Gopalaswamy, R., Aravindhan, V., & Subbian, S. (2024) · Biomolecules · doi:10.3390/biom14101320 · Cited by 7
Interaction between host G3BP and viral nucleocapsid protein regulates SARS-CoV-2 replicationPreprint
Yang, Z., Johnson, B. A., Meliopoulos, V., Ju, X., Zhang, P., Hughes, M. P., Wu, J., Koreski, K. P., Chang, T., Wu, G., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.06.29.546885 · Cited by 7
Morgenstern, C., Rawson, T., Routledge, I., Kont, M., Imai-Eaton, N., Skarp, J., Doohan, P., McCain, K., Johnson, R., Unwin, H. J. T., et al. (2025) · The Lancet Microbe · doi:10.1016/j.lanmic.2025.101144 · Cited by 6
Graphene-based materials as nanoplatforms for antiviral therapy and prophylaxis
Iannazzo, D., Giofrè, S. V., Espro, C., & Celesti, C. (2024) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2024.2364652 · Cited by 6
Strategies of rational and structure-driven vaccine design for Arenaviruses
Peter, A. S., Hoffmann, D. S., Klier, J., Lange, C. M., Moeller, J., Most, V., Wüst, C. K., Beining, M., Güleşen, S., Junker, H., et al. (2024) · Infection Genetics and Evolution · doi:10.1016/j.meegid.2024.105626 · Cited by 6
Tian, C., Liu, H., Wang, Q., Zhao, J., Yao, C., Yao, Y., Zhang, X., Ma, Q., Wang, W., Zhou, Y., et al. (2024) · Engineering · doi:10.1016/j.eng.2024.07.007 · Cited by 6
Moussaoui, M. E., Bontems, S., Meex, C., Hayette, M., Lejeune, M., Hong, S. L., Dellicour, S., Moutschen, M. P., Cambisano, N., Renotte, N., et al. (2024) · Virus Evolution · doi:10.1093/ve/veae073 · Cited by 7
Tramontozzi, C., Riccio, A., Pauciullo, S., Frazia, S. L., Rossi, A., & Santoro, M. G. (2024) · Journal of Virus Eradication · doi:10.1016/j.jve.2024.100387 · Cited by 6
Verma, S., Dubey, A., Singh, R., Tayade, R. P., & Mishra, V. K. (2025) · ChemistrySelect · doi:10.1002/slct.202403269 · Cited by 6
Sukik, L., Chemaitelly, H. S., Ayoub, H. H., Coyle, P. V., Tang, P., Hasan, M. R., Yassine, H. M., Thani, A. A. A., Kanaani, Z. A., Al‐Kuwari, E., et al. (2025) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofaf098 · Cited by 6
Koyambo-Konzapa, S., Oubella, A., Altharawi, A., & Aldakhil, T. (2025) · Journal of Molecular Graphics and Modelling · doi:10.1016/j.jmgm.2025.108987 · Cited by 6
Łoboda, D., Golba, K. S., Gurowiec, P. J., Bredelytė, A., Razbadauskas, A., & Sarecka‐Hujar, B. (2025) · Life · doi:10.3390/life15040520 · Cited by 7
RBD-depleted SARS-CoV-2 spike generates protective immunity in cynomolgus macaques
Letscher, H., Guilligay, D., Effantin, G., Amen, A., Sulbarán, G., Burger, J. A., Bossevot, L., Junges, L., Léonec, M., Morin, J., et al. (2025) · npj Vaccines · doi:10.1038/s41541-025-01113-0 · Cited by 6
Akagawa, M., Sugasawa, K., Ura, K., & Sassa, A. (2025) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2025.108512 · Cited by 7
Predictive modeling of immune escape and antigenic grouping of SARS-CoV-2 variants
Nasir, A., Lee, D. W., Avena, L. E., Berrueta, D. M., Speidel, T., Wu, K., Budigi, Y., Carfı́, A., Stewart-Jones, G. B. E., & Edwards, D. K. (2026) · Journal of Virology · doi:10.1128/jvi.00225-26 · Cited by 6
Molecular mechanisms of SARS-CoV-2 entry: implications for biomedical strategies
Santamaria-Castro, I., Leiva-Rebollo, R., Marín‐Wong, S., Jiménez-Guardeño, J. M., & Ortega‐Prieto, A. M. (2025) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00260-24 · Cited by 7
Metadata
- Authors
- Markov, P. V., Ghafari, M., Beer, M., Lythgoe, K., Simmonds, P., Stilianakis, N. I., & Katzourakis, A.
- Affiliations
- University of London (GB)
- University of Oxford (GB)
- Friedrich-Loeffler-Institut (DE)
- Friedrich-Alexander-Universität Erlangen-Nürnberg (DE)
- Corresponding author
- Markov, Peter V.
- Katzourakis, Aris
- ORCID
- Venue
- Nature Reviews Microbiology
- Published
- 2023-04-05
- Volume
- 21
- Issue
- 6
- Pages
- 361-379
- ISSN
- 1740-1526 (ISSN-L)
- 1740-1534
- OpenAlex
- W4362609000
- Semantic Scholar
- b6c3324e790174aac7a7b28fcfe0bc22f5461418
- Cited by
- 1,179
- References
- 225
- Citations by year
- 2026: 204 · 2025: 390 · 2024: 441 · 2023: 130
- FWCI
- 55.63
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Nature Reviews Microbiology (publishedVersion)
- PubMed (publishedVersion)
- LSHTM Research Online (London School of Hygiene and Tropical Medicine) (acceptedVersion)
- OpenAgrar (submittedVersion)
- Funders
- Wellcome Trust (107652/Z/15/Z)
- H2020 European Research Council (101001623)
- Topics
- Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Evolution and Genetic Dynamics
- Life Sciences › Agricultural and Biological Sciences › Animal Science and Zoology › Animal Virus Infections Studies
- Keywords
- SARS-CoV-2, viral evolution, genetic variation, variants of concern, antigenic evolution, immune evasion, reinfection, recombination, chronic infection, reservoir hosts, transmissibility, disease severity, COVID-19 pandemic, evolutionary trajectories
- MeSH terms
- COVID-19, SARS-CoV-2, Animals, Genomics, Immune Evasion, Pandemics
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
